These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 2922988

  • 1. Neuroendocrine markers in central nervous system neuronal tumors (gangliocytoma and ganglioglioma).
    Takahashi H, Wakabayashi K, Kawai K, Ikuta F, Tanaka R, Takeda N, Washiyama K.
    Acta Neuropathol; 1989; 77(3):237-43. PubMed ID: 2922988
    [Abstract] [Full Text] [Related]

  • 2. An ultrastructural and immunohistochemical evaluation of cytodifferentiation in neuroblastic tumors.
    Hachitanda Y, Tsuneyoshi M, Enjoji M.
    Mod Pathol; 1989 Jan; 2(1):13-9. PubMed ID: 2922387
    [Abstract] [Full Text] [Related]

  • 3. Immunohistochemical and ultrastructural analysis of bronchopulmonary neuroendocrine neoplasms. I. Carcinoids.
    Warren WH, Memoli VA, Gould VE.
    Ultrastruct Pathol; 1984 Jan; 6(1):15-27. PubMed ID: 6375057
    [Abstract] [Full Text] [Related]

  • 4. Studies with the Golgi method in central gangliogliomas and dysplastic gangliocytoma of the cerebellum (Lhermitte-Duclos disease).
    Ferrer I, Martí E, Guionnet N, Bella R, Serrano T, Towse J, Conesa G, Isamat F.
    Histol Histopathol; 1990 Jul; 5(3):329-36. PubMed ID: 1724930
    [Abstract] [Full Text] [Related]

  • 5. Neuroendocrine carcinoma of the stomach with extensive somatostatin immunoreactivity.
    Chejfec G, Kovarick P, Graham G, Eichorst M, Gould VE.
    Ultrastruct Pathol; 1992 Jul; 16(5):537-45. PubMed ID: 1359688
    [Abstract] [Full Text] [Related]

  • 6. Primitive neuroectodermal tumors of the central nervous system. Patterns of expression of neuroendocrine markers, and all classes of intermediate filament proteins.
    Gould VE, Jansson DS, Molenaar WM, Rorke LB, Trojanowski JQ, Lee VM, Packer RJ, Franke WW.
    Lab Invest; 1990 Apr; 62(4):498-509. PubMed ID: 2159086
    [Abstract] [Full Text] [Related]

  • 7. Intestinal ganglioneuromatosis: mucosal and transmural types. A clinicopathologic and immunohistochemical study of six cases.
    d'Amore ES, Manivel JC, Pettinato G, Niehans GA, Snover DC.
    Hum Pathol; 1991 Mar; 22(3):276-86. PubMed ID: 1706307
    [Abstract] [Full Text] [Related]

  • 8. Cerebral and cerebellar gangliocytomas: a morphological study of nine cases.
    Felix I, Bilbao JM, Asa SL, Tyndel F, Kovacs K, Becker LE.
    Acta Neuropathol; 1994 Mar; 88(3):246-51. PubMed ID: 7810295
    [Abstract] [Full Text] [Related]

  • 9. [Histological diagnosis of brain tumors: (3) Gangliocytoma (ganglioglioma)].
    Tamura M.
    No Shinkei Geka; 1989 Apr; 17(4):311-7. PubMed ID: 2671773
    [No Abstract] [Full Text] [Related]

  • 10. Regulatory peptides in neuronal neoplasms of the central nervous system.
    Giangaspero F, Burger PC, Budwit DA, Usellini L, Mancini AM.
    Clin Neuropathol; 1985 Apr; 4(3):111-5. PubMed ID: 2861927
    [Abstract] [Full Text] [Related]

  • 11. Coexpression of neuroendocrine markers and epithelial cytoskeletal proteins in bronchopulmonary neuroendocrine neoplasms.
    Blobel GA, Gould VE, Moll R, Lee I, Huszar M, Geiger B, Franke WW.
    Lab Invest; 1985 Jan; 52(1):39-51. PubMed ID: 2981372
    [Abstract] [Full Text] [Related]

  • 12. Somatostatin and vasoactive intestinal peptide (VIP) in neuroblastoma and ganglioneuroma: chromatographic characterisation and release during surgery.
    Bjellerup P, Theodorsson E, Kogner P.
    Eur J Cancer; 1995 Jan; 31A(4):481-5. PubMed ID: 7576950
    [Abstract] [Full Text] [Related]

  • 13. [The occurrence of tyrosine hydroxylase-immunoreactive neurons in a parietal lobe ganglioglioma].
    Wakabayashi K, Takahashi H, Ikuta F, Yamada N, Watanabe T, Tanaka R.
    No To Shinkei; 1989 Feb; 41(2):165-70. PubMed ID: 2567605
    [Abstract] [Full Text] [Related]

  • 14. The neuroendocrine and neural profiles of neuroblastomas, ganglioneuroblastomas, and ganglioneuromas.
    Molenaar WM, Baker DL, Pleasure D, Lee VM, Trojanowski JQ.
    Am J Pathol; 1990 Feb; 136(2):375-82. PubMed ID: 1689542
    [Abstract] [Full Text] [Related]

  • 15. A clinicopathologic and immunomorphologic study of 13 cases of ganglioglioma.
    Diepholder HM, Schwechheimer K, Mohadjer M, Knoth R, Volk B.
    Cancer; 1991 Nov 15; 68(10):2192-201. PubMed ID: 1913457
    [Abstract] [Full Text] [Related]

  • 16. Morphology of experimental tumors of the sympathetic nervous system.
    Beniashvili DS.
    Exp Pathol; 1990 Nov 15; 39(2):89-94. PubMed ID: 2401351
    [Abstract] [Full Text] [Related]

  • 17. Gangliocytoma of the cerebellum: ultrastructure and immunohistochemistry.
    Izukawa D, Lach B, Benoit B.
    Neurosurgery; 1988 Mar 15; 22(3):576-81. PubMed ID: 3362326
    [Abstract] [Full Text] [Related]

  • 18. Molecular markers of primitive neuroectodermal tumors and other pediatric central nervous system tumors. Monoclonal antibodies to neuronal and glial antigens distinguish subsets of primitive neuroectodermal tumors.
    Molenaar WM, Jansson DS, Gould VE, Rorke LB, Franke WW, Lee VM, Packer RJ, Trojanowski JQ.
    Lab Invest; 1989 Dec 15; 61(6):635-43. PubMed ID: 2557487
    [Abstract] [Full Text] [Related]

  • 19. Adrenal pheochromocytoma-ganglioneuroma producing catecholamines and various neuropeptides.
    Salmi J, Pelto-Huikko M, Auvinen O, Karvonen AL, Saaristo J, Paronen I, Pöyhönen L, Seppänen S.
    Acta Med Scand; 1988 Dec 15; 224(4):403-8. PubMed ID: 3188992
    [Abstract] [Full Text] [Related]

  • 20. Myosin XVA expression in the pituitary and in other neuroendocrine tissues and tumors.
    Lloyd RV, Vidal S, Jin L, Zhang S, Kovacs K, Horvath E, Scheithauer BW, Boger ET, Fridell RA, Friedman TB.
    Am J Pathol; 2001 Oct 15; 159(4):1375-82. PubMed ID: 11583965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.